MedTrace Logo

The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery

NCT05498025 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2024-01-19

No results posted yet for this study

Summary

Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain as a "Surgeon General Priority" that needs urgent investigation.

Hypothesis: At least 33% of postpartum women discharged home with an opioid prescription and a drug deactivation pouch will use the pouch to dispose of remaining opioids within 30 days of delivery.

Methods: This is a prospective single arm interventional pilot study.

Conditions

  • Pain, Acute
  • Opioid Misuse
  • Obstetric Pain
  • Cesarean Section Complications

Interventions

OTHER

Deterra activated charcoal pouch

drug disposal pouch

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Michael J Paglia · Geisinger Clinic

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-21
Primary Completion
2023-07-29
Completion
2023-07-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498025 on ClinicalTrials.gov